Simplex Trading
TERN

Simplex Trading’s Terns Pharmaceuticals TERN Stock Holding History

Simplex Trading’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
26,900
+21,100
+364% +$867K ﹤0.01% 2136
2025
Q4 		$234K Buy
5,800
+3,600
+164% +$83.2K ﹤0.01% 4064
2025
Q3 		$16K Buy
2,200
+100
+5% +$639 ﹤0.01% 7556
2025
Q2 		$7K Sell
2,100
-400
-16% -$1.25K ﹤0.01% 7587
2025
Q1 		$6K Sell
2,500
-3,400
-58% -$13.9K ﹤0.01% 7488
2024
Q4 		$32K Sell
5,900
-46,800
-89% -$317K ﹤0.01% 6296
2024
Q3 		$439K Buy
52,700
+45,900
+675% +$378K ﹤0.01% 3734
2024
Q2 		$46K Buy
6,800
+1,600
+31% +$9.69K ﹤0.01% 6182
2024
Q1 		$34K Buy
5,200
+4,900
+1,633% +$32K ﹤0.01% 6652
2023
Q4 		$1K Buy
+300
New +$1.59K ﹤0.01% 8587
2023
Q3 		– Sell
-8,600
Closed -$75K – 9813
2023
Q2 		$75K Buy
+8,600
New +$100K ﹤0.01% 5417

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Simplex Trading's TERN Position: Q3 2025 in Review

Simplex Trading sold out of Terns Pharmaceuticals (TERN) in Q3 2025, closing a stake of 14,650 shares — an estimated $93.5K sold.

Simplex Trading first reported a position in TERN in Q2 2023 and held it in 5 quarters. The position peaked at $357K in Q2 2023. 141 funds tracked by Wall St. Rank hold TERN as of Q3 2025.

  • Simplex Trading reported no remaining Terns Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 14,650 Terns Pharmaceuticals shares in Q3 2025, an estimated $93.5K.
  • Simplex Trading first reported a position in Terns Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • Simplex Trading's Terns Pharmaceuticals position peaked at $357K in Q2 2023.
  • 141 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.